Siili Solutions Oyj
Siili Solutions Plc: Share Repurchase 18.6.2025
Siili Solutions Plc: Share Repurchase 18.6.2025
Siili Solutions Plc | Announcement 18.6.2025 | |
Siili Solutions Plc: Share Repurchase 18.6.2025 | ||
In the Helsinki Stock Exchange | ||
Trade date | 18.6.2025 | |
Bourse trade | Buy | |
Share | SIILI | |
Amount | 1 300 | Shares |
Average price/ share | 6,2800 | EUR |
Total cost | 8 164,00 | EUR |
Siili Solutions Plc now holds a total of 14 998 shares | ||
including the shares repurchased on 18.6.2025 | ||
The share buybacks are executed in compliance with Regulation | ||
No. 596/2014 of the European Parliament and Council (MAR) Article 5 | ||
and the Commission Delegated Regulation (EU) 2016/1052. | ||
On behalf of Siili Solutions Plc | ||
Nordea Bank Oyj | ||
Sami Huttunen | Ilari Isomäki | |
Further information: | ||
CFO Aleksi Kankainen | ||
Email: aleksi.kankainen@siili.com | ||
Tel. +358 50 584 2029 | ||
www.siili.com | ||
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Mandalay Resources Corporation18.6.2025 23:00:00 CEST | Press release
Mandalay Announces Receipt of Swedish Regulatory Approval for Proposed Merger of Equals
Galapagos NV18.6.2025 22:01:00 CEST | Press release
Galapagos Presented New Data at ICML 2025 From Cohort 3 of ATALANTA-1 in Relapsed/Refractory Indolent NHL Patients, Demonstrating High Complete Response and MRD Negativity Rates With CAR-T Candidate GLPG5101
1000 Miglia S.r.l.18.6.2025 18:34:51 CEST | Press release
1000 Miglia 2025: the arrival tonight in the capital
Zealand Pharma18.6.2025 17:29:44 CEST | Press release
Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide
Dassault Aviation18.6.2025 17:05:32 CEST | Press release
Dassault Aviation: Collaboration between AMIAD and Dassault Aviation
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom